{
  "fullName": "Lotte Bjerre Knudsen",
  "slug": "lotte-bjerre-knudsen",
  "title": "MD",
  "specialty": "Medicine",
  "geography": {
    "country": "Unknown",
    "city": "Unknown",
    "region": "Unknown"
  },
  "status": "LIVING",
  "tier": "UNRANKED",
  "rankingScore": 25.54,
  "hIndex": 59,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Lotte Bjerre Knudsen is a Danish scientist and university professor. She led the development of liraglutide and oversaw the development of semaglutide, two notable drugs approved for indications in the treatment of diabetes and obesity.",
  "aiSummary": "Lotte Bjerre Knudsen is a medicine specialist with an H-index of 59. Has been published in Science Translational Medicine, JACC Basic to Translational Science, Proceedings of the National Academy of Sciences. Based in Unknown, Unknown, Unknown.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [],
  "socialMedia": {},
  "affiliations": [],
  "medicalSpecialty": [
    "Medicine"
  ],
  "knowsAbout": [],
  "citations": [
    {
      "title": "Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide",
      "journal": "Journal of Medicinal Chemistry",
      "year": 2015,
      "citationCount": 958,
      "doi": "10.1021/acs.jmedchem.5b00726",
      "sourceUrl": "https://doi.org/10.1021/acs.jmedchem.5b00726",
      "verified": true
    },
    {
      "title": "The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss",
      "journal": "Journal of Clinical Investigation",
      "year": 2014,
      "citationCount": 881,
      "doi": "10.1172/jci75276",
      "sourceUrl": "https://doi.org/10.1172/jci75276",
      "verified": true
    },
    {
      "title": "The Discovery and Development of Liraglutide and Semaglutide",
      "journal": "Frontiers in Endocrinology",
      "year": 2019,
      "citationCount": 838,
      "doi": "10.3389/fendo.2019.00155",
      "sourceUrl": "https://doi.org/10.3389/fendo.2019.00155",
      "verified": true
    },
    {
      "title": "GLP-1 Receptor Localization in Monkey and Human Tissue: Novel Distribution Revealed With Extensively Validated Monoclonal Antibody",
      "journal": "Endocrinology",
      "year": 2014,
      "citationCount": 801,
      "doi": "10.1210/en.2013-1934",
      "sourceUrl": "https://doi.org/10.1210/en.2013-1934",
      "verified": true
    },
    {
      "title": "Potent Derivatives of Glucagon-like Peptide-1 with Pharmacokinetic Properties Suitable for Once Daily Administration",
      "journal": "Journal of Medicinal Chemistry",
      "year": 2000,
      "citationCount": 681,
      "doi": "10.1021/jm9909645",
      "sourceUrl": "https://doi.org/10.1021/jm9909645",
      "verified": true
    },
    {
      "title": "Glucagon-Like Peptide-1 Receptor Agonists Activate Rodent Thyroid C-Cells Causing Calcitonin Release and C-Cell Proliferation",
      "journal": "Endocrinology",
      "year": 2010,
      "citationCount": 623,
      "doi": "10.1210/en.2009-1272",
      "sourceUrl": "https://doi.org/10.1210/en.2009-1272",
      "verified": true
    },
    {
      "title": "Semaglutide lowers body weight in rodents via distributed neural pathways",
      "journal": "JCI Insight",
      "year": 2020,
      "citationCount": 614,
      "doi": "10.1172/jci.insight.133429",
      "sourceUrl": "https://doi.org/10.1172/jci.insight.133429",
      "verified": true
    },
    {
      "title": "Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist",
      "journal": "Science Translational Medicine",
      "year": 2018,
      "citationCount": 471,
      "doi": "10.1126/scitranslmed.aar7047",
      "sourceUrl": "https://doi.org/10.1126/scitranslmed.aar7047",
      "verified": true
    },
    {
      "title": "The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE−/− and LDLr−/− Mice by a Mechanism That Includes Inflammatory Pathways",
      "journal": "JACC Basic to Translational Science",
      "year": 2018,
      "citationCount": 432,
      "doi": "10.1016/j.jacbts.2018.09.004",
      "sourceUrl": "https://doi.org/10.1016/j.jacbts.2018.09.004",
      "verified": true
    },
    {
      "title": "Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity",
      "journal": "Diabetologia",
      "year": 1998,
      "citationCount": 297,
      "doi": "10.1007/s001250050903",
      "sourceUrl": "https://doi.org/10.1007/s001250050903",
      "verified": true
    },
    {
      "title": "Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor",
      "journal": "Journal of Biological Chemistry",
      "year": 2009,
      "citationCount": 283,
      "doi": "10.1074/jbc.m109.033829",
      "sourceUrl": "https://doi.org/10.1074/jbc.m109.033829",
      "verified": true
    },
    {
      "title": "Structure-activity studies of glucagon-like peptide-1.",
      "journal": "Journal of Biological Chemistry",
      "year": 1994,
      "citationCount": 280,
      "doi": "10.1016/s0021-9258(17)37366-0",
      "sourceUrl": "https://doi.org/10.1016/s0021-9258(17)37366-0",
      "verified": true
    },
    {
      "title": "The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases β-cell mass in diabetic mice",
      "journal": "American Journal of Physiology-Endocrinology and Metabolism",
      "year": 2002,
      "citationCount": 280,
      "doi": "10.1152/ajpendo.00030.2002",
      "sourceUrl": "https://doi.org/10.1152/ajpendo.00030.2002",
      "verified": true
    },
    {
      "title": "Systemic Administration of the Long-Acting GLP-1 Derivative NN2211 Induces Lasting and Reversible Weight Loss in Both Normal and Obese Rats",
      "journal": "Diabetes",
      "year": 2001,
      "citationCount": 258,
      "doi": "10.2337/diabetes.50.11.2530",
      "sourceUrl": "https://doi.org/10.2337/diabetes.50.11.2530",
      "verified": true
    },
    {
      "title": "Expression of the GLP-1 Receptor in Mouse, Rat, and Human Pancreas",
      "journal": "Journal of Histochemistry & Cytochemistry",
      "year": 2008,
      "citationCount": 247,
      "doi": "10.1369/jhc.2008.951319",
      "sourceUrl": "https://doi.org/10.1369/jhc.2008.951319",
      "verified": true
    },
    {
      "title": "Glucagon-like peptide-1-(9-36) amide is a major metabolite of glucagon-like peptide-1-(7-36) amide after in vivo administration to dogs, and it acts as an antagonist on the pancreatic receptor",
      "journal": "European Journal of Pharmacology",
      "year": 1996,
      "citationCount": 246,
      "doi": "10.1016/s0014-2999(96)00795-9",
      "sourceUrl": "https://doi.org/10.1016/s0014-2999(96)00795-9",
      "verified": true
    },
    {
      "title": "Structure−Activity and Protraction Relationship of Long-Acting Glucagon-like Peptide-1 Derivatives:  Importance of Fatty Acid Length, Polarity, and Bulkiness",
      "journal": "Journal of Medicinal Chemistry",
      "year": 2007,
      "citationCount": 239,
      "doi": "10.1021/jm070861j",
      "sourceUrl": "https://doi.org/10.1021/jm070861j",
      "verified": true
    },
    {
      "title": "Small-molecule agonists for the glucagon-like peptide 1 receptor",
      "journal": "Proceedings of the National Academy of Sciences",
      "year": 2007,
      "citationCount": 223,
      "doi": "10.1073/pnas.0605701104",
      "sourceUrl": "https://doi.org/10.1073/pnas.0605701104",
      "verified": true
    },
    {
      "title": "Liraglutide, a Long-Acting Glucagon-Like Peptide-1 Analog, Reduces Body Weight and Food Intake in Obese Candy-Fed Rats, Whereas a Dipeptidyl Peptidase-IV Inhibitor, Vildagliptin, Does Not",
      "journal": "Diabetes",
      "year": 2006,
      "citationCount": 204,
      "doi": "10.2337/db06-0565",
      "sourceUrl": "https://doi.org/10.2337/db06-0565",
      "verified": true
    },
    {
      "title": "GLP‐1 derivative liraglutide in rats with <i>β</i>‐cell deficiencies: influence of metabolic state on <i>β</i>‐cell mass dynamics",
      "journal": "British Journal of Pharmacology",
      "year": 2003,
      "citationCount": 198,
      "doi": "10.1038/sj.bjp.0705397",
      "sourceUrl": "https://doi.org/10.1038/sj.bjp.0705397",
      "verified": true
    },
    {
      "title": "A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE<sup>-/-</sup> mouse model",
      "journal": "Diabetes and Vascular Disease Research",
      "year": 2011,
      "citationCount": 192,
      "doi": "10.1177/1479164111404257",
      "sourceUrl": "https://doi.org/10.1177/1479164111404257",
      "verified": true
    },
    {
      "title": "Expression and Distribution of Glucagon-Like Peptide-1 Receptor mRNA, Protein and Binding in the Male Nonhuman Primate (<i>Macaca mulatta</i>) Brain",
      "journal": "Endocrinology",
      "year": 2014,
      "citationCount": 183,
      "doi": "10.1210/en.2014-1675",
      "sourceUrl": "https://doi.org/10.1210/en.2014-1675",
      "verified": true
    },
    {
      "title": "A long-acting glucagon-like peptide-1 analogue attenuates induction of plasminogen activator inhibitor type-1 and vascular adhesion molecules",
      "journal": "Journal of Endocrinology",
      "year": 2009,
      "citationCount": 183,
      "doi": "10.1677/joe-08-0468",
      "sourceUrl": "https://doi.org/10.1677/joe-08-0468",
      "verified": true
    },
    {
      "title": "Treatment with glucagon‐like peptide‐1 receptor agonists and incidence of dementia: Data from pooled double‐blind randomized controlled trials and nationwide disease and prescription registers",
      "journal": "Alzheimer s & Dementia Translational Research & Clinical Interventions",
      "year": 2022,
      "citationCount": 180,
      "doi": "10.1002/trc2.12268",
      "sourceUrl": "https://doi.org/10.1002/trc2.12268",
      "verified": true
    },
    {
      "title": "The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer’s Disease",
      "journal": "Journal of Alzheimer s Disease",
      "year": 2015,
      "citationCount": 176,
      "doi": "10.3233/jad-143090",
      "sourceUrl": "https://doi.org/10.3233/jad-143090",
      "verified": true
    },
    {
      "title": "Liraglutide: short‐lived effect on gastric emptying—long lasting effects on body weight",
      "journal": "Diabetes Obesity and Metabolism",
      "year": 2012,
      "citationCount": 174,
      "doi": "10.1111/j.1463-1326.2012.01557.x",
      "sourceUrl": "https://doi.org/10.1111/j.1463-1326.2012.01557.x",
      "verified": true
    },
    {
      "title": "The long-acting glucagon-like peptide-1 analogue, liraglutide, inhibits β-cell apoptosis in vitro",
      "journal": "Biochemical and Biophysical Research Communications",
      "year": 2005,
      "citationCount": 168,
      "doi": "10.1016/j.bbrc.2005.03.013",
      "sourceUrl": "https://doi.org/10.1016/j.bbrc.2005.03.013",
      "verified": true
    },
    {
      "title": "A genetic map of the mouse dorsal vagal complex and its role in obesity",
      "journal": "Nature Metabolism",
      "year": 2021,
      "citationCount": 159,
      "doi": "10.1038/s42255-021-00363-1",
      "sourceUrl": "https://doi.org/10.1038/s42255-021-00363-1",
      "verified": true
    },
    {
      "title": "Glucagon-like Peptide-1:  The Basis of a New Class of Treatment for Type 2 Diabetes",
      "journal": "Journal of Medicinal Chemistry",
      "year": 2004,
      "citationCount": 155,
      "doi": "10.1021/jm030630m",
      "sourceUrl": "https://doi.org/10.1021/jm030630m",
      "verified": true
    },
    {
      "title": "The Glucagon-Like Peptide-1 Receptor—or Not?",
      "journal": "Endocrinology",
      "year": 2012,
      "citationCount": 151,
      "doi": "10.1210/en.2012-2124",
      "sourceUrl": "https://doi.org/10.1210/en.2012-2124",
      "verified": true
    },
    {
      "title": "Long-term characterization of the diet-induced obese and diet-resistant rat model: a polygenetic rat model mimicking the human obesity syndrome",
      "journal": "Journal of Endocrinology",
      "year": 2010,
      "citationCount": 151,
      "doi": "10.1677/joe-10-0004",
      "sourceUrl": "https://doi.org/10.1677/joe-10-0004",
      "verified": true
    },
    {
      "title": "Using genetic association data to guide drug discovery and development: Review of methods and applications",
      "journal": "The American Journal of Human Genetics",
      "year": 2023,
      "citationCount": 141,
      "doi": "10.1016/j.ajhg.2022.12.017",
      "sourceUrl": "https://doi.org/10.1016/j.ajhg.2022.12.017",
      "verified": true
    },
    {
      "title": "GLP-1 Receptor Agonists and the Thyroid: C-Cell Effects in Mice Are Mediated via the GLP-1 Receptor and not Associated with RET Activation",
      "journal": "Endocrinology",
      "year": 2012,
      "citationCount": 138,
      "doi": "10.1210/en.2011-1864",
      "sourceUrl": "https://doi.org/10.1210/en.2011-1864",
      "verified": true
    },
    {
      "title": "Different domains of the glucagon and glucagon‐like peptide‐1 receptors provide the critical determinants of ligand selectivity",
      "journal": "British Journal of Pharmacology",
      "year": 2003,
      "citationCount": 131,
      "doi": "10.1038/sj.bjp.0705120",
      "sourceUrl": "https://doi.org/10.1038/sj.bjp.0705120",
      "verified": true
    },
    {
      "title": "Characterization of the Glucagonlike Peptide-1 Receptor in Male Mouse Brain Using a Novel Antibody and In Situ Hybridization",
      "journal": "Endocrinology",
      "year": 2017,
      "citationCount": 131,
      "doi": "10.1210/en.2017-00812",
      "sourceUrl": "https://doi.org/10.1210/en.2017-00812",
      "verified": true
    },
    {
      "title": "The Human GLP-1 Analog Liraglutide and the Pancreas",
      "journal": "Diabetes",
      "year": 2012,
      "citationCount": 122,
      "doi": "10.2337/db11-0936",
      "sourceUrl": "https://doi.org/10.2337/db11-0936",
      "verified": true
    },
    {
      "title": "Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products–induced inflammation",
      "journal": "Kidney International",
      "year": 2023,
      "citationCount": 104,
      "doi": "10.1016/j.kint.2023.09.029",
      "sourceUrl": "https://doi.org/10.1016/j.kint.2023.09.029",
      "verified": true
    },
    {
      "title": "GLP-1 Induces Barrier Protective Expression in Brunnerʼs Glands and Regulates Colonic Inflammation",
      "journal": "Inflammatory Bowel Diseases",
      "year": 2016,
      "citationCount": 97,
      "doi": "10.1097/mib.0000000000000847",
      "sourceUrl": "https://doi.org/10.1097/mib.0000000000000847",
      "verified": true
    },
    {
      "title": "Liraglutide: the therapeutic promise from animal models",
      "journal": "International Journal of Clinical Practice",
      "year": 2010,
      "citationCount": 95,
      "doi": "10.1111/j.1742-1241.2010.02499.x",
      "sourceUrl": "https://doi.org/10.1111/j.1742-1241.2010.02499.x",
      "verified": true
    },
    {
      "title": "The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy",
      "journal": "Brain Research",
      "year": 2015,
      "citationCount": 92,
      "doi": "10.1016/j.brainres.2015.12.052",
      "sourceUrl": "https://doi.org/10.1016/j.brainres.2015.12.052",
      "verified": true
    },
    {
      "title": "Discovery and Structure−Activity Relationship of the First Non-Peptide Competitive Human Glucagon Receptor Antagonists",
      "journal": "Journal of Medicinal Chemistry",
      "year": 1998,
      "citationCount": 92,
      "doi": "10.1021/jm9810304",
      "sourceUrl": "https://doi.org/10.1021/jm9810304",
      "verified": true
    },
    {
      "title": "Integrated Brain Atlas for Unbiased Mapping of Nervous System Effects Following Liraglutide Treatment",
      "journal": "Scientific Reports",
      "year": 2018,
      "citationCount": 92,
      "doi": "10.1038/s41598-018-28496-6",
      "sourceUrl": "https://doi.org/10.1038/s41598-018-28496-6",
      "verified": true
    },
    {
      "title": "Liraglutide, a Once‐daily Human Glucagon‐like Peptide‐1 Analog, Minimizes Food Intake in Severely Obese Minipigs",
      "journal": "Obesity",
      "year": 2007,
      "citationCount": 91,
      "doi": "10.1038/oby.2007.204",
      "sourceUrl": "https://doi.org/10.1038/oby.2007.204",
      "verified": true
    },
    {
      "title": "The effects of 13 wk of liraglutide treatment on endocrine and exocrine pancreas in male and female ZDF rats: a quantitative and qualitative analysis revealing no evidence of drug-induced pancreatitis",
      "journal": "American Journal of Physiology-Endocrinology and Metabolism",
      "year": 2012,
      "citationCount": 91,
      "doi": "10.1152/ajpendo.00182.2012",
      "sourceUrl": "https://doi.org/10.1152/ajpendo.00182.2012",
      "verified": true
    },
    {
      "title": "A survey of the mouse hindbrain in the fed and fasted states using single-nucleus RNA sequencing",
      "journal": "Molecular Metabolism",
      "year": 2021,
      "citationCount": 90,
      "doi": "10.1016/j.molmet.2021.101240",
      "sourceUrl": "https://doi.org/10.1016/j.molmet.2021.101240",
      "verified": true
    },
    {
      "title": "Multivariate near-infrared and Raman spectroscopic quantifications of the crystallinity of lactose in whey permeate powder",
      "journal": "International Dairy Journal",
      "year": 2005,
      "citationCount": 90,
      "doi": "10.1016/j.idairyj.2004.12.009",
      "sourceUrl": "https://doi.org/10.1016/j.idairyj.2004.12.009",
      "verified": true
    },
    {
      "title": "The truncated metabolite GLP-2 (3–33) interacts with the GLP-2 receptor as a partial agonist",
      "journal": "Regulatory Peptides",
      "year": 2002,
      "citationCount": 88,
      "doi": "10.1016/s0167-0115(01)00316-0",
      "sourceUrl": "https://doi.org/10.1016/s0167-0115(01)00316-0",
      "verified": true
    },
    {
      "title": "Optimization of Alkylidene Hydrazide Based Human Glucagon Receptor Antagonists. Discovery of the Highly Potent and Orally Available 3-Cyano-4-hydroxybenzoic Acid [1-(2,3,5,6-Tetramethylbenzyl)-1<i>H</i>-indol-4-ylmethylene]hydrazide",
      "journal": "Journal of Medicinal Chemistry",
      "year": 2002,
      "citationCount": 86,
      "doi": "10.1021/jm0208572",
      "sourceUrl": "https://doi.org/10.1021/jm0208572",
      "verified": true
    },
    {
      "title": "GLP-1 analogue, Liraglutide protects human umbilical vein endothelial cells against high glucose induced endoplasmic reticulum stress",
      "journal": "Regulatory Peptides",
      "year": 2011,
      "citationCount": 79,
      "doi": "10.1016/j.regpep.2011.11.008",
      "sourceUrl": "https://doi.org/10.1016/j.regpep.2011.11.008",
      "verified": true
    },
    {
      "title": "Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in culture",
      "journal": "Transplant International",
      "year": 2009,
      "citationCount": 78,
      "doi": "10.1111/j.1432-2277.2009.00984.x",
      "sourceUrl": "https://doi.org/10.1111/j.1432-2277.2009.00984.x",
      "verified": true
    }
  ],
  "awards": [],
  "timeline": [],
  "openalexId": "https://openalex.org/A5088627727"
}